GELTEQ LIMITED
GELS·Q3978B109·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic
GELS (GELTEQ LIMITED) is held by 4 institutional investors as of Q1 2026. Largest holders: Private Advisor Group, LLC ($11,018), CITADEL ADVISORS LLC ($8,991), TWO SIGMA INVESTMENTS, LP ($6,644). Net institutional sentiment: Mixed.
4
Holders
Avg rating(1 Elite)
$27,865
Total Value
60% (5)
Fund Consensus
3 buying - 2 selling
No verdict yet — fewer than 2 funds hold GELS.
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer